Literature DB >> 27886357

Anterior iliopsoas impingement due to a malpositioned acetabular component - effective relief by surgical cup reorientation.

Benjamin Schoof1,2, Oliver Jakobs2, Stefan Schmidl1, Christian Lausmann1, Florian Fensky2, Johannes Beckmann3, Thorsten Gehrke1, Matthias Gebauer1,4.   

Abstract

BACKGROUND: Determining the aetiology of persistent pain following total hip arthroplasty (THA) can be challenging. Impingement of the iliopsoas muscle due to a malpositioned acetabular component after THA might be a potential cause of postoperative groin pain.
METHODS: We retrospectively analysed the data of 12 consecutive patients from our orthopaedic department who underwent cup revision for painful iliopsoas impingement after primary THA.
RESULTS: Thorough physical examination as well as radiological assessment of the included patients revealed that malpositioning of the acetabular component provoked iliopsoas impingement.The Harris Hip Score and the orientation of the acetabular component before and after surgical revision at an average follow-up of 56 months were analysed.
CONCLUSIONS: We were able to demonstrate that surgical cup revision and reorientation resulted in distinctly improved scores and is a feasible option to effectively treat persistent iliopsoas impingement due to a malpositioned acetabular component following THA.

Entities:  

Mesh:

Year:  2016        PMID: 27886357     DOI: 10.5301/hipint.5000443

Source DB:  PubMed          Journal:  Hip Int        ISSN: 1120-7000            Impact factor:   2.135


  2 in total

1.  Surgical Management of Iliopsoas Impingement With Combined Acetabular Revision and Partial Psoas Tenotomy.

Authors:  Andrew Yun; Marilena Qutami; Kory B Pasko
Journal:  Cureus       Date:  2021-02-07

2.  Reconstruction of the Anterior Acetabular Wall to Repair Symptomatic Defects Consecutive to Cup Malpositioning at Total Hip Arthroplasty.

Authors:  Lara Pozzi; Aude Lehnen; Fabian Kalberer; Christoph Meier; Peter Wahl
Journal:  Arthroplast Today       Date:  2020-12-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.